Article
Characterizing and forecasting neoantigens-resulting from MUC mutations in COAD.
Journal of translational medicine - 27 Mar 2024
Chen Min, Zhang Xin, Ming Zihe, Lingyu, Feng Xiaorong, Han Zhenguo, An Han-Xiang
Abstract excerpt
BACKGROUND: The treatment for colon adenocarcinoma (COAD) faces challenges in terms of immunotherapy effectiveness due to multiple factors. Because of the high tumor specificity and immunogenicity, neoantigen has been considered a pivotal target for cancer immunotherapy. Therefore, this study aims to identify and predict the potential tumor antigens of MUC somatic mutations (MUCmut) in COAD. METHODS: Three...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
